Protocol for a systematic evaluation of pediatric pharmacy development and pediatric pharmacy experts' research area in China

• Published in: Medicine (Baltimore) Vol. 97; no. 50; p. e13597
• Main Authors: Li, Hao, Huang, Shi-Ying, Zhang, Shun-Guo, Chen, Min-Ling, Gu, Zhi-Chun, Shi, Fang-Hong
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer Health 01.12.2018
• Subjects: China; Clinical Protocols; Delivery of Health Care - methods; Humans; Pediatrics - methods; Pediatrics - standards; Pharmacy Service, Hospital - methods; Pharmacy Service, Hospital - standards; Program Development - methods; Program Development - standards; Study Protocol Systematic Review; China
• ISSN: 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000013597

The pediatric pharmacy research status of children's hospitals in China is still unknown. Our previous findings suggest the regional differences in academic level in tertiary (grade III level A) children's hospitals in China. This systemic evaluation described in this protocol will be conducted to follow the Cochrane Handbook. We will perform a systemic literature search of relevant databases including Chinese databases (CNKI, Wanfang Data, VIP Paper Check System) and English databases (Medline, EMbase, Cochrane Library) from inception to December 31, 2018. The search strategy will be enacted according to the guidance offered from the Cochrane Handbook. Two rounds of searches will be conducted to prevent the omission of relevant literature. A pre-set grading standard will be used to give calculation weight (W) to evaluate the quality of each article. Data synthesis will be performed using STATA software (version 13.1, Statacorp, College Station, Texas). Pediatric pharmacy development index (PPDI) of each hospital will be used to evaluate the pediatric pharmacy development in each tertiary children's hospitals. The cumulative calculation weight (∑W) and annual calculation weight (∑yearW) will be used to evaluate the academic level of pharmaceutical departments in different tertiary children's hospitals. Subgroup analysis will be performed to compare the number of different types of articles published between different hospitals base on different research areas such as policy research, basic research, and clinical research. In this article, we will evaluate pediatric pharmacy development and the research area of pediatric pharmacy experts in China. Based on the results from this research, we will analyze the professional backgrounds of pediatric pharmacy experts from 23 tertiary children's hospitals in China. According to the contents and research directions of literature published by the pediatric pharmacy experts in these 23 hospitals, we will determine the professional field of pediatric pharmacy experts and establish an expert database. In the process of formulating the related national or local policies in the future, the expert database will be selected accurately to reach the expert consensus. Our study will provide a comprehensive picture of pediatric pharmacy development in China. The pediatrics pharmacy expert's database constructed by this study will be used to build consensus on pediatric pharmacology in the future.